Who Paid My Doc
Epi-Sense Guided Coagulation System With Visitrax
Device Cardiovascular
PDI 10840143900327
General payments
$10,335,211
Research payments
$847,474
Through program year 2025, $10,335,211 in general payments and $847,474 in research payments were reported against Epi-Sense Guided Coagulation System With Visitrax (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,749,779 | 7,382 |
| 2025 | Research | $423,432 | 191 |
| 2024 | General | $1,815,535 | 7,800 |
| 2024 | Research | $133,967 | 28 |
| 2023 | General | $2,415,364 | 9,506 |
| 2023 | Research | $263,925 | 78 |
| 2022 | General | $2,485,217 | 7,635 |
| 2022 | Research | $26,150 | 33 |
| 2021 | General | $1,869,315 | 4,968 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 81 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
37,291 general · 330 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.